iTeos Therapeutics, Inc. ITOS
Set alert
10.15 0.00 0.00%
At close · Aug 29
10.15 Day range 10.15
52-week range unavailable
- YTD
- +32.16%
- 1 year
- -40.82%
- Open
- 10.15
- Prev close
- 10.15
- Mkt cap
- 448.68M
- Vol
- 11.01M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.15
- High
- 10.15
- Forward P/E
- -1.26
- Beta
- 1.39
- Short ratio
- 3.66
- Inst. own
- 103.92%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 8.57
- 200-d avg
- 12.79
- 1y target
- 25.00
5Y chart
Events in this range
- Mar 6, 2024Earnings: —; estimate -1.03; surprise —%
- May 10, 2024Earnings: -1.07; estimate -1.02; surprise -4.9%
- May 10, 2024Earnings: —; estimate -1.02; surprise —%
- Aug 8, 2024Earnings: -0.18; estimate -1.04; surprise 82.69%
- Aug 8, 2024Earnings: —; estimate -1.04; surprise —%
- Aug 12, 2024Rating: JP Morgan · Overweight → Overweight
- Aug 13, 2024Rating: Wells Fargo · — → Overweight
- Sep 16, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Nov 12, 2024Earnings: -1.05; estimate -1.18; surprise 11.02%
- Nov 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 13, 2024Rating: HC Wainwright & Co. · Buy → Buy
- Dec 19, 2024Rating: Wells Fargo · Overweight → Overweight
Signals (54)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Aug 25, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| SMA: Bearish | May 9, 2025 | 1 year ago |
| SMA: Bearish | May 9, 2025 | 1 year ago |
| SMA: Bullish | May 2, 2025 | 1 year ago |
| SMA: Bullish | Apr 25, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 17, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 10, 2025 | 1 year ago |
| RSI: Oversold | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 30, 2025 | 1 year ago |
| SMA: Bearish | Sep 16, 2024 | 2 years ago |
| SMA: Bearish | Sep 9, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 9, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 26, 2024 | 2 years ago |
| SMA: Bullish | Aug 19, 2024 | 2 years ago |
| MACD: Sell Signal | Aug 12, 2024 | 2 years ago |
| SMA: Bearish | Aug 5, 2024 | 2 years ago |
| SMA: Bullish | Jul 15, 2024 | 2 years ago |
| SMA: Bearish | Jun 24, 2024 | 2 years ago |
Newest 20 of 54.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 25.00 +146.3% upside
Now 10.15
- Target (low)
- 16.00
- Target (mean)
- 25.00
- Target (high)
- 47.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy3
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.02 | -1.48 – -0.78 | -0.85 | -20.2% | 0 | 0.0% | 4 |
| Next quarter | -0.99667 | -1.44 – -0.74 | -1.07 | +6.9% | 0 | 0.0% | 3 |
| Current year | -3.15 | -3.73 – -2.59 | -3.15 | +0.1% | 35.00M | +177.9% | 4 |
| Next year | -3.66 | -5.84 – -2.61 | -3.15 | -16.2% | 7.48M | -78.6% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 19, 2024 | Wells Fargo | Maintained | Overweight | Overweight |
| Dec 13, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 15, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2024 | Wells Fargo | Initiated | — | Overweight |
| Aug 12, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| May 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 12, 2024 | JP Morgan | Maintained | Overweight | Overweight |
| Mar 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 13, 2023 | JP Morgan | Maintained | Overweight | Overweight |
| Oct 18, 2023 | Wedbush | Reiterated | Outperform | Outperform |
| Aug 9, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Mar 17, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 16, 2023 | JP Morgan | Maintained | — | Overweight |
| Mar 16, 2023 | Wedbush | Maintained | — | Outperform |
| May 13, 2022 | SVB Leerink | Maintained | — | Outperform |
| Dec 13, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 12, 2021 | SVB Leerink | Maintained | — | Outperform |
| Aug 13, 2021 | SVB Leerink | Maintained | — | Outperform |
| May 19, 2021 | SVB Leerink | Maintained | — | Outperform |
| May 5, 2021 | HC Wainwright & Co. | Initiated | — | Buy |
| Apr 6, 2021 | SVB Leerink | Maintained | — | Outperform |
| Nov 19, 2020 | SVB Leerink | Maintained | — | Outperform |
| Oct 8, 2020 | Baird | Initiated | — | Outperform |
| Aug 18, 2020 | JP Morgan | Initiated | — | Overweight |
| Aug 18, 2020 | Wedbush | Initiated | — | Outperform |
| Aug 18, 2020 | SVB Leerink | Initiated | — | Outperform |
| Aug 18, 2020 | Piper Sandler | Initiated | — | Overweight |